Fusion Pharmaceuticals provides manufacturing update
Canadian Manufacturing
JANUARY 5, 2024
HAMILTON and BOSTON — Fusion Pharmaceuticals Inc., 4 that it has completed validation of its good manufacturing practice (GMP) manufacturing facility and produced the first clinical dose of a TAT. “We achieved alignment with the U.S. . “We achieved alignment with the U.S. ” Fusion reported on Jan.
Let's personalize your content